Title:
dopa -- a constituent for continuous medication of decarboxylase inhibitor
Document Type and Number:
Japanese Patent JP6157678
Kind Code:
B2
Abstract:
Disclosed herein are pharmaceutically acceptable liquid compositions comprising arginine and a combination of carbidopa and levodopa as active agents suitable for continuous administration for treating neurological or movement diseases or disorders such as restless leg syndrome, Parkinson's disease, secondary parkinsonism, Huntington's disease, Parkinson's-like syndrome, PSP, MSA, ALS, Shy-Drager syndrome and conditions resulting from brain injury including carbon monoxide or manganese intoxication.
Inventors:
Jacoby-Zybi, Olon
Nemas, Mara
Nemas, Mara
Application Number:
JP2016078121A
Publication Date:
July 05, 2017
Filing Date:
April 08, 2016
Export Citation:
Assignee:
Neuroderm Limited
International Classes:
A61K31/198; A61K9/08; A61K31/12; A61K31/165; A61K31/275; A61K47/02; A61K47/20; A61K47/22; A61K47/32; A61K47/42; A61P21/00; A61P25/00; A61P25/14; A61P25/16; A61P43/00
Domestic Patent References:
| JP55009023A | ||||
| JP2003503454A | ||||
| JP2008505966A |
Foreign References:
| WO2007138086A1 |
Other References:
Expert Rev. Neurotherapeutics,2006年,Vol.6, No.10,p.1403-1411
Attorney, Agent or Firm:
Asamura patent office
Previous Patent: High frequency electric discharge igniter
Next Patent: PRODUCTION OF PAPER SURFACE COATING AGENT AND ITS USE
Next Patent: PRODUCTION OF PAPER SURFACE COATING AGENT AND ITS USE